ARTICLE | Clinical News
Ampakine Org 24448: Began Phase II trial
September 24, 2001 7:00 AM UTC
N.V. Organon, Oss, the Netherlands Product: Ampakine Org 24448 Business: Neurological Therapeutic category: Neurotransmission Target: AMPA glutamate receptor Description: Ampakine enhancer of the AMP...